Peer-Reviewed Study Reports on New Blood Test for Early Breast Cancer Detection
A new peer-reviewed study details a blood test for early-stage breast cancer, reporting over 92% sensitivity and specificity. Researchers indicate the test's performance surpasses current supplemental screening methods. The study comes from a team at Astrin Biosciences.
Advertisement
SAINT PAUL, Minn. – Researchers published a new peer-reviewed study detailing the capabilities of a blood test for early-stage breast cancer detection. The study appeared in a scientific journal on July 30, 2026.
The authors, affiliated with Astrin Biosciences, reported the test demonstrated a sensitivity exceeding 92% and a specificity exceeding 92%. These metrics, they indicate, surpass the performance of current supplemental screening standards.
Astrin Biosciences, a company focused on cancer detection and treatment, developed the test. Researchers developed the blood test using deep proteomics, a method involving the large-scale study of proteins.
The company states this technology enables the analysis of numerous proteins within a blood sample. This analysis aims to identify early indicators of breast cancer.
Related Topics
Article Ratings
How do you feel about this story?
National Desk
Sign in to follow this author from their profile.
Discussion (0)
Join the Conversation
Join the conversation
Sign in to share your thoughts, reply to readers, and like comments.
No comments yet. Be the first to comment!